glp-1 obesity drug news october 9 2025 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC Overview of GLP-1s

Whats less often discussed is that the number on the scale doesnt tell the full story

For the description of metabolism, most studies have been drawn from these two groups: constraint-based models (or stoichiometric models) and kinetic models (Gombert & Nielsen, 2000

For this reason, it should always be taken away from supplements and medications by at least 1-2 hours unless otherwise directed by a healthcare professional

Patients must not self-medicate

No published receptor binding constant or characterised minimum effective concentration anchors the dose, so dose decisions rest on preclinical envelopes. TB-4: cell migration What it is TB-4 is a naturally occurring 43-amino-acid peptide involved in cell movement and tissue repair